| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/11/2022 | Vigil Neuroscience, Inc. | | Conversion | Common stock | 193k | $0.00 | $0 | | 01/11/2022 |
| 01/11/2022 | Vigil Neuroscience, Inc. | | Conversion | Series A convertible preferred stock | 392.6k | $0.00 | $0 | | 01/11/2022 |
| 01/11/2022 | Vigil Neuroscience, Inc. | | Conversion | Series B convertible preferred stock | 142.5k | $0.00 | $0 | | 01/11/2022 |
| 10/26/2021 | Xilio Therapeutics, Inc. | | Conversion | Series B convertible preferred stock | 1.6M | $0.00 | $0 | | 10/26/2021 |
| 10/26/2021 | Xilio Therapeutics, Inc. | | Conversion | Common stock | 166.4k | $0.00 | $0 | | 10/26/2021 |
| 06/01/2021 | Singular Genomics Systems, Inc. | | Conversion | Common stock | 2.6M | $0.00 | $0 | | 06/01/2021 |
| 06/01/2021 | Singular Genomics Systems, Inc. | | Conversion | Series A convertible preferred stock | 1.8M | $0.00 | $0 | | 06/01/2021 |
| 06/01/2021 | Singular Genomics Systems, Inc. | | Conversion | Series B convertible preferred stock | 849.3k | $0.00 | $0 | | 06/01/2021 |
| 02/09/2021 | Vor Biopharma Inc. | | Conversion | Series B convertible preferred stock | 3.8M | $0.00 | $0 | | 02/09/2021 |
| 02/09/2021 | Vor Biopharma Inc. | | Conversion | Common stock | 282.8k | $0.00 | $0 | | 02/09/2021 |
| 12/08/2020 | ARS Pharmaceuticals, Inc. | SBTX | Conversion | Common stock | 699.4k | $0.00 | $0 | | 12/08/2020 |
| 12/08/2020 | ARS Pharmaceuticals, Inc. | SBTX | Conversion | Series A redeemable convertible preferred stock | 1.4M | $0.00 | $0 | | 12/08/2020 |
| 12/08/2020 | ARS Pharmaceuticals, Inc. | SBTX | Conversion | Series B redeemable convertible preferred stock | 1.2M | $0.00 | $0 | | 12/08/2020 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Conversion | Common stock | 1.3M | $0.00 | $0 | | 09/18/2020 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Purchase | Common stock | 38.5k | $13.00 | $500k | | 09/18/2020 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Conversion | Series A convertible preferred stock | 4.6M | $0.00 | $0 | | 09/18/2020 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Conversion | Series B convertible preferred stock | 1.1M | $0.00 | $0 | | 09/18/2020 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Conversion | Series C convertible preferred stock | 763k | $0.00 | $0 | | 09/18/2020 |
| 08/25/2020 | Kymera Therapeutics, Inc. | | Conversion | Common Stock | 467.9k | $0.00 | $0 | | 08/25/2020 |
| 08/25/2020 | Kymera Therapeutics, Inc. | | Conversion | Series A convertible preferred stock | 500k | $0.00 | $0 | | 08/25/2020 |
| 08/25/2020 | Kymera Therapeutics, Inc. | | Conversion | Series B convertible preferred stock | 246.3k | $0.00 | $0 | | 08/25/2020 |
| 07/20/2020 | Relay Therapeutics, Inc. | RLAY | Conversion | Common Stock | 968.4k | $0.00 | $0 | | 07/20/2020 |
| 07/20/2020 | Relay Therapeutics, Inc. | RLAY | Conversion | Series A Preferred Stock | 500k | $0.00 | $0 | | 07/20/2020 |
| 07/20/2020 | Relay Therapeutics, Inc. | RLAY | Conversion | Series B Preferred Stock | 1.3M | $0.00 | $0 | | 07/20/2020 |
| 07/20/2020 | Relay Therapeutics, Inc. | RLAY | Conversion | Series C Preferred Stock | 1.7M | $0.00 | $0 | | 07/20/2020 |
| 06/16/2020 | Avidity Biosciences, Inc. | RNA | Conversion | Common stock | 502.4k | $0.00 | $0 | | 06/16/2020 |
| 06/16/2020 | Avidity Biosciences, Inc. | RNA | Conversion | Series A convertible preferred stock | 395k | $0.00 | $0 | | 06/16/2020 |
| 06/16/2020 | Avidity Biosciences, Inc. | RNA | Conversion | Series B convertible preferred stock | 530.6k | $0.00 | $0 | | 06/16/2020 |
| 06/16/2020 | Avidity Biosciences, Inc. | RNA | Conversion | Series C convertible preferred stock | 134.1k | $0.00 | $0 | | 06/16/2020 |
| 03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Conversion | Common Stock | 293k | $0.00 | $0 | | 03/16/2020 |
| 03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Conversion | Series Seed Preferred Stock | 125.4k | $0.00 | $0 | | 03/16/2020 |
| 03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Conversion | Series A Preferred Stock | 1.4M | $0.00 | $0 | | 03/16/2020 |
| 03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Conversion | Series B Preferred Stock | 287k | $0.00 | $0 | | 03/16/2020 |
| 10/07/2019 | Frequency Therapeutics, Inc. | FREQ | Conversion | Series B Convertible Preferred Stock | 2.3M | $0.00 | $0 | | 10/07/2019 |
| 10/07/2019 | Frequency Therapeutics, Inc. | FREQ | Conversion | Common Stock | 956.2k | $0.00 | $0 | | 10/07/2019 |
|